# exp67-first-contact

session `sess_5528aa58f585`

## USER

D:\Libraries\Documents\projects\OPAL\67_2026.04.09_OPAL.0002_Weston_PC\67_2026.04.09_OPAL.0002_Weston_PC

what is this data?

## ASSISTANT (2347.7s, stop=end_turn)

The user supplied a bundle root. I’ll load the APPL-CORE export procedure before checking its version or interpreting the data.


The export procedure supports only version 6. I’ll read the supplied bundle’s manifest to check `export_version` before proceeding.


The manifest identifies this as APPL-CORE export version 6, which is supported. I’ll load the onboarding procedure to check whether this export already has a current experiment card before analysing it.


The manifest confirms export version 6. I’ll check whether this bundle already has a current experiment card so I can reuse its validated views rather than profile the data again.


The card matches the manifest, but it is still a draft: there is no loader, no views, and no recorded hashes. It cannot yet support an answer. I’ll read the draft to see what onboarding work remains.


The card matches the manifest but is only a draft, with no loader or validated views. I’ll delegate onboarding of this version 6 export, then independently rerun the returned loader and verify its hashes before answering.


The onboarding child is running. I’ll wait for its results, then rerun the exact loader command it reports and verify the view hashes before answering.


The child’s result was too large to display in the wait response. I’ll retrieve its full output to get the exact loader command, artifact paths, and verification result before independently checking the views.


The child reports completed views and matching hashes. I’ll independently rerun the exact loader command it provided, then verify the hashes before answering from the experiment card.


The loader completed successfully. I’ll run `card.py verify` against the supplied bundle and workspace to confirm the regenerated views match the recorded hashes before answering.


The loader rerun succeeded, and `card.py verify` reports matching hashes with no drift. I’ll read the completed experiment card and load the evidence procedure so the answer describes this export with sourced, appropriately qualified claims.


The loader rerun succeeded and the view hashes match. I can answer from the verified experiment card, while distinguishing documented facts from unresolved meanings.


**This is an APPL-CORE plant-phenotyping export** for experiment 67, named `2026.04.09_OPAL.0002_Weston_PC`. It is export version 6, generated on 2026-09-02. [stated; source: `manifest.json`, `experiment`, `export_version`, `generated_at`]

- **Experiment design:** 360 plants, with 12 genotype labels and six treatment labels (`0`, `50`, `100`, `200`, `500`, `1000`); each genotype–treatment combination has five plants. [checked; source: `experiment-card.md`, “Checked facts,” full design-table check]
- **Measurements:** repeated imaging and derived plant traits from FC1, RGB2 (top-view images), MSC1, VNIR and SWIR (spectral measurements), and S3D, plus plant-weight records. The export also references image, mask, point-cloud, and plant-surface assets. [stated; sources: `manifest.json`, `modalities` and `top_level_files`; `docs/experiment-export-summary.md`, “Modality Status” and “Feature Families”]
- **Analysis status:** a loader produced validated design, observation, spectra, asset, and event views. I reran it, and `card.py verify` reported matching hashes with no drift. [checked; sources: loader output and `card.py verify`; card: `D:\Libraries\Documents\projects\opal-work\live\ws\.clio\datasets\76bf90275f7a9839\experiment-card.md`]

**Important caveats:** The treatment labels look numeric, but their intervention and dose unit are not documented, so they have been kept as categories. [inferred; source: design labels and `experiment-card.md`, “Open questions”; confirm with experiment owners] The FC1 data contain 328,740 unflagged float-maximum values, which the loader treats as missing while leaving the raw export unchanged. [checked; source: `experiment-card.md`, FC1 full-column audit and loader decision] The meaning of zero weights and the timezone of measurement timestamps also remain open questions. [checked; source: `experiment-card.md`, “Open questions for data owners”]

## USER

does the nickel hurt growth?

## ASSISTANT (427.1s, stop=end_turn)

The export already has verified views. I’ll load the growth and treatment-analysis procedures, then compare growth across the recorded treatment groups. The dose unit is still unknown, so I won’t assume one.


I’ll use the already-verified views to compare plant-level growth across treatment labels, without treating repeated images as independent plants. The user identifies the treatment as nickel, but its dose unit remains unconfirmed; I’ll keep the levels categorical and report that limitation. First, I’ll load the evidence procedure and review the card’s trait and quality notes.


The verified card establishes the treatment groups and available observations, but not whether growth differs between them. I’ll inspect the design and observation view schemas to identify a suitable growth trait and compare plants—not repeated images—as replicates.


The observation file is not named `observations_000.parquet`; that path was an incorrect guess. I’ll list the validated view filenames and use the actual observation file.


I found the validated observation filenames. I’ll inspect the RGB2 and S3D schemas to identify a documented size trait before comparing plant-level growth across treatment groups.


The RGB2 and S3D views have the fields needed for a plant-level comparison. I’ll identify the available S3D size traits and their units before choosing a growth measure; the schema alone does not establish which trait is appropriate.


The pandas groupby tool tried to read the Parquet file as CSV, so it cannot be used for this view. I’ll use `uv run` with PyArrow to list the S3D plant traits, methods, scales, and counts before selecting a growth measure.


The PyArrow command failed because PowerShell stripped the nested quotes before Python received it; no data were read. I’ll correct the quoting and list the S3D plant traits, methods, and scales.


The current `uv` environment lacks PyArrow, so the trait listing did not run. I’ll use a temporary PyArrow dependency with `uv run --with pyarrow` to inspect the validated S3D view without changing the export.


S3D provides projected plant area in `mm2` at repeated time points. I’ll check its date coverage, QC flags, missing values, and value range before using it to compare growth by treatment.


S3D projected-area measurements cover different numbers of plants on different dates, so an unadjusted overall mean could be misleading. I’ll check plant-level coverage and median area by treatment label on each date, then choose a comparison window that accounts for genotype and repeated measurements. I’ll exclude the five nonpositive area readings as unusable for growth.


S3D median projected area falls sharply after April 23, which could reflect changing plant coverage or a measurement issue rather than growth. I’ll cross-check the available RGB2 size traits before drawing a conclusion about nickel. I’ll continue treating the treatment labels as categories because their dose unit is unconfirmed.


RGB2 has repeated top-view area measurements, but the trait list alone does not establish whether its metric scale and masks are suitable for comparing growth. I’ll read the export’s RGB2 documentation before analysing plant-level trajectories.


The RGB2 documentation describes projected area as a canopy-growth proxy, but warns that its millimetre scale is hard-coded. I’ll load the instrument guidance, then check mask provenance and image-edge clipping before comparing pixel-area trajectories across treatment groups.


I’ll inspect the RGB2 source columns for mask selection, image boundaries, and QC fields. Those checks are needed before treating changes in projected area as plant growth.


The RGB2 source has mask paths, bounding-box coordinates, ROI bounds, image dimensions, and QC flags. I’ll inspect representative values and mask-path coverage first; that will show which boundaries are comparable before I calculate clipping or use RGB2 area as a growth proxy.


Nearly all RGB2 rows carry `low_mask_coverage`; that flag does not, by itself, establish that their area measurements are unusable. I’ll check how many positive area measurements remain on each date, whether their bounding boxes touch the recorded ROI edges, and whether the export identifies which mask produced the features. I won’t infer a nickel effect from these measurements until those checks are resolved.


RGB2 bounding-box contact rises sharply after April 28, so I’ll restrict this comparison to earlier dates. I’ll compare pixel-area changes for the same plants, check results by genotype, and keep the unknown mask provenance and nickel dose unit as caveats.


The RGB2 comparison suggests that plants in the `500` and especially `1000` groups had less projected-area growth than the `0` group before widespread ROI-edge contact. I’ll check whether that pattern holds across genotypes and assess the unequal measurement coverage before drawing a conclusion. I’ll first load the phenotyping design-check procedure.


The design has five plants per genotype–treatment cell, but usable RGB2 coverage differs by treatment. I’ll compare April 14–27 growth within each genotype using paired plants with positive, non-edge-contact pixel-area measurements. This will show whether the apparent reduction in the `500` and `1000` groups is consistent across genotypes rather than driven by their mix.


The paired RGB2 measurements show substantially less projected-area growth in the highest treatment groups, including within most genotypes. I can answer the question as a qualified association, not a confirmed causal or dose-response result: the user identifies the treatment as nickel, but the export does not establish its dose unit, and measurement coverage and mask quality limit certainty.


**Probably yes at the higher treatment levels, especially `1000`—but this is evidence of reduced canopy expansion, not proof that nickel caused it.** [inferred; evidence: the paired RGB2 comparison below; nickel identity supplied by you]

[checked; source: plant-level comparison of the validated RGB2 `area_px` views, April 14–27] Median increase in top-view projected area was **66,586.5 pixels** for the `0` group (48 paired plants), **38,426 pixels** for `500` (39 plants), and **10,620 pixels** for `1000` (39 plants). Measurements from the same plant on the same day were combined, and images whose plant bounding box touched the recorded ROI edge were excluded. The `500` group had a lower median increase than `0` in 10 of 11 comparable genotypes; `1000` did so in 10 of 12. [checked; source: genotype-by-treatment paired comparison of those views]

**Caveats:** RGB2 projected area is a growth proxy, not biomass. [stated; source: `docs/modalities/RGB2.md`, “Scope And Biological Meaning”] Usable measurement coverage differs among groups, nearly all RGB2 rows carry a `low_mask_coverage` flag, and this comparison has no uncertainty interval or formal treatment-effect model. [checked; sources: RGB2 feature QC check and paired-coverage comparison] The export does not document the nickel dose unit or establish that `0` is an untreated control; those meanings should be confirmed before calling this a dose-response effect. [inferred; source: experiment card’s open treatment question and your identification of nickel] **What do the treatment labels measure, and in what unit?**

## USER

show me the growth curves

## ASSISTANT (308.0s, stop=end_turn)

The export’s validated views and earlier growth checks are available. I’ll load the interactive-analysis procedure, then plot observed RGB2 pixel-area trajectories by treatment with measurement coverage and quality caveats.


I’ll load the workspace chart catalog so I can show the observed RGB2 growth trajectories using a supported chart component.


The interactive chart catalog is not available to this expert. I’ll make a static growth-curve figure instead, using the validated RGB2 views. First I’ll read the experiment card for the exact view paths and quality rules.


The interactive chart catalog is unavailable, so I’ll prepare a static figure from the validated RGB2 views. I’ll locate the exact observation files and review the card’s RGB2 quality notes before calculating daily growth curves.


I found the validated RGB2 observation files. I’ll inspect their schema to confirm the date, plant, treatment, area, and QC fields before calculating the curves.


The RGB2 view is a long-format trait table; treatment labels and the image-boundary checks may need to come from other validated or source tables. I’ll locate those files before calculating daily plant-level curves.


I found the validated design view and the RGB2 source tables. I’ll inspect their schemas to identify the treatment join key and image-boundary fields before calculating daily plant-level growth curves.


The schemas identify the necessary fields. I’ll check representative rows and the RGB2 trait label so I can join treatment groups correctly and apply the same positive-area and ROI-edge filters used in the earlier comparison.


The validated RGB2 view contains `area_px`, and its source table contains the ROI and bounding-box fields needed to exclude edge-contact images. I’ll calculate daily plant-level medians for April 14–27, then check how many plants contribute to each treatment curve before plotting.


The April 14–27 data support a matched-plant growth chart. I’ll plot median RGB2 projected area for each treatment group, with interquartile bands and a second panel showing the number of plants measured each day. This keeps unequal coverage visible and uses the same positive-area, non-edge-contact filter as the earlier comparison.


The growth-curve figure and its daily summary table were generated. I’ll inspect the figure to verify its labels, curves, and coverage panel before sharing it.


The figure shows the six treatment curves and daily plant counts, but two dash characters rendered as question marks. I’ll correct those labels before sharing it.


![RGB2 growth curves by treatment label](rgb2_growth_curves_apr14_27.png)

[checked; sources: validated RGB2 observations, design view, and `rgb2_growth_curves_apr14_27.csv`] These curves show **daily median top-view projected area** from April 14–27. Each line represents plants measured on both endpoint dates; shading shows the 25th–75th percentiles, and the lower panel shows how many plants contributed each day. The `1000` group’s curve rises much less than the `0` group’s. [checked; source: plotted daily summary]

[checked; sources: RGB2 observations and source image bounds] The calculation uses positive area readings whose plant bounding boxes do not touch the recorded ROI edge, combining repeat images into one median per plant per day. [stated; source: `docs/modalities/RGB2.md`] Projected area is a canopy-growth proxy, not biomass. [inferred; source: experiment card’s open treatment question] The treatment unit and whether `0` is an untreated control remain unconfirmed, so the lines are labeled by recorded treatment category rather than nickel dose.

[Download the daily values and plant counts](rgb2_growth_curves_apr14_27.csv).
